Biomarqueurs en cancérologie et onco-hématologie (BECCOH)

Laboratory presentation

The research activities of the BECCOH laboratory concern clinical trials and the development of biomarkers, for patients with cutaneous, digestive or pulmonary cancers, or histocytoses. The laboratory's teams aim for strong cross-sections, particularly around the development and validation of predictive and prognostic biomarkers allowing an ever increasing specification of the therapeutic management of patients. The BECCOH laboratory has a histological and molecular pathology platform for the study of neoplasia, and is backed by a center of biological resources (CRB) certified by AFNOR to NF96-900 standard.